Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial.

Ludvigsson, J; Hjorth, M; Chéramy, M; Axelsson, S; Pihl, M; Forsander, G; Nilsson, N-Ö; Samuelsson, B-O; Wood, T; Aman, J; Ortqvist, E; Casas, R

Ludvigsson, J; Hjorth, M; Chéramy, M; Axelsson, S; Pihl, M; Forsander, G; Nilsson, N-Ö; Samuelsson, B-O; Wood, T; Aman, J; Ortqvist, E; Casas, R.

Affiliation

Ludvigsson J; Division of Pediatrics, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, SE-58185, Linköping, Sweden. johnny.ludvigsson@lio.se

Diabetologia ; 54(3): 634-40, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21116604

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Glutamate Decarboxylase/therapeutic use; Adolescent; C-Peptide/metabolism; Child; Diabetes Mellitus, Type 1/metabolism; Double-Blind Method; Female; Glutamate Decarboxylase/adverse effects; Humans; Male; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Glutamate Decarboxylase Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Diabetologia Year: 2011 Document type: Article Affiliation country: Sweden Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google